How migraines impact cognitive function: findings from the Baltimore ECA.
Vale
Salvador
S
D015142:Baltimore; D001921:Brain / Q000378:metabolism* / Q000503:physiopathology; D003072:Cognition Disorders / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D004298:Dopamine / Q000378:metabolism*; D018491:Dopamine Agonists / Q000494:pharmacology / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008569:Memory Disorders / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D020325:Migraine with Aura / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D015854:Up-Regulation / Q000502:physiology*
D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D004298:Dopamine